A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, SARS2) remains a great global health threat and demands identification of more effective and SARS2-targeted antiviral drugs, even with successful development of anti-SARS2 vaccines. Viral replicons have proven to be a rapid, safe, and...
Main Authors: | Ying Liu, Lu Li, Khalid A. Timani, Johnny J. He |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/5/974 |
Similar Items
-
A rewinding model for replicons with DNA-links
by: Abdul Adheem Mohamad, et al.
Published: (2020-02-01) -
Zika Virus Replicons for Drug Discovery
by: Xuping Xie, et al.
Published: (2016-10-01) -
Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle
by: Loy John Dustin, et al.
Published: (2013-01-01) -
Autonomous replication sequences from the Amaranthus palmeri eccDNA replicon enable replication in yeast
by: William T. Molin, et al.
Published: (2020-07-01) -
Construction of a Chikungunya Virus, Replicon, and Helper Plasmids for Transfection of Mammalian Cells
by: Mayra Colunga-Saucedo, et al.
Published: (2022-12-01)